Abstract PR423

S. Amornyotin, S. Kongphlay
  • Anesthesia & Analgesia, September 2016, Wolters Kluwer Health
  • DOI: 10.1213/01.ane.0000492810.76942.48

Propofol Deep Sedation for RFA in Sick Elderly Patients with Hepatocellular Carcinoma

What is it about?

The aim of this study was to evaluate and compare the clinical efficacy of propofol-based deep sedation (PBDS) for percutaneous radiofrequency ablation (RFA) in sick (American Society of Anesthesiologists [ASA] physical status III-IV) and nonsick (ASA physical status I-II) elderly patients in a teaching hospital in Thailand.

Why is it important?

There were 113 elderly patients who underwent RFA procedure by using PBDS during the study period. Of these, 69 patients were in group A and 44 patients were in group B. There were no significant differences in age, gender, weight, duration of procedure, and mean dose of propofol, fentanyl, and midazolam between the two groups. All procedures in both groups were successfully completed. Overall and cardiorespiratory adverse events in both groups were not significantly different. All adverse events were easily treated, with no adverse sequelae.


Somchai Amornyotin
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

PBDS for percutaneous RFA in sick elderly patients by trained anesthetic personnel with appropriate monitoring was safe and effective. The clinical efficacy of this technique in sick elderly patients was not different or worse than in nonsick elderly patients. Serious adverse events were rare.

Read Publication


The following have contributed to this page: Somchai Amornyotin